Accendra Health, Inc.
ACH
$3.23
$0.072.22%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 88.52% | 62.52% | 82.71% | -3,378.74% | 91.56% |
| Total Depreciation and Amortization | 106.68% | -53.40% | 7.91% | 38.45% | 334.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 59.69% | -277.09% | -91.45% | 1,633.37% | -114.62% |
| Change in Net Operating Assets | -128.18% | 238.55% | -270.48% | 2,623.33% | -107.49% |
| Cash from Operations | -173.44% | 139.52% | -558.71% | 207.25% | -149.39% |
| Capital Expenditure | -217.11% | 75.79% | 20.08% | -48.23% | -105.76% |
| Sale of Property, Plant, and Equipment | 291.95% | 33.95% | 1.35% | 7.32% | 213.83% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 98.34% | -1,316.02% | -13.43% | 83.63% | -26.78% |
| Cash from Investing | -81.08% | 822.19% | 25.42% | -9.79% | 7.85% |
| Total Debt Issued | -43.02% | -41.86% | -4.79% | 9.81% | -4.69% |
| Total Debt Repaid | 59.67% | 20.26% | 17.05% | -20.05% | 19.87% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | 100.00% | -242.85% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.11% | -203.03% | 7,105.71% | 79.87% | 68.89% |
| Cash from Financing | 143.48% | -164.88% | 471.30% | -65.83% | 315.28% |
| Foreign Exchange rate Adjustments | -131.78% | 479.41% | -102.70% | 132.29% | 141.41% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -76.72% | 862.66% | -275.18% | 75.56% | 139.11% |